U.S. Takes Inspection Appeal To WHO
This article was originally published in PharmAsia News
On the heels of signing two memoranda of understanding with China, the United States says it wants an international certification system for imported products. Health and Human Services Secretary Mike Leavitt signed the memoranda during a recent trip to China, requiring China to strengthen its own safety checks on drug supplies. Speaking to the annual assembly of the World Health Organization in Geneva, Leavitt said no nation could ensure the safety of imported products by inspecting at its borders. Instead, they rely on a "collaborative system of international standards and local controls." (Click here for more
You may also be interested in...
Mexico's Genomma Lab recorded strong double-digit growth for its OTC business in the second quarter as sales more than doubled at its US consumer health operation.
New board directors named at Autolus Therapeutics, Beximco Pharmaceuticals, Tetraphase Pharmaceuticals and Vesigen.
After launching a biosimilar to Avastin (bevacizumab) in India, Cadila Pharma has now also launched rituximab and teriparatide biosimilars in its domestic market.